These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28117600)

  • 41. OneBac 2.0: Sf9 Cell Lines for Production of AAV1, AAV2, and AAV8 Vectors with Minimal Encapsidation of Foreign DNA.
    Mietzsch M; Hering H; Hammer EM; Agbandje-McKenna M; Zolotukhin S; Heilbronn R
    Hum Gene Ther Methods; 2017 Feb; 28(1):15-22. PubMed ID: 28125901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors.
    Mohiuddin I; Loiler S; Zolotukhin I; Byrne BJ; Flotte TR; Snyder RO
    Mol Ther; 2005 Feb; 11(2):320-6. PubMed ID: 15668144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Manufacturing recombinant adeno-associated viral vectors from producer cell clones.
    Thorne BA; Takeya RK; Peluso RW
    Hum Gene Ther; 2009 Jul; 20(7):707-14. PubMed ID: 19848592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms.
    Robert MA; Chahal PS; Audy A; Kamen A; Gilbert R; Gaillet B
    Biotechnol J; 2017 Mar; 12(3):. PubMed ID: 28177193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of Versatile and Flexible Sf9 Packaging Cell Line-Dependent OneBac System for Large-Scale Recombinant Adeno-Associated Virus Production.
    Wu Y; Mei T; Jiang L; Han Z; Dong R; Yang T; Xu F
    Hum Gene Ther Methods; 2019 Oct; 30(5):172-183. PubMed ID: 31566024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
    Liu XL; Clark KR; Johnson PR
    Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel and highly efficient production system for recombinant adeno-associated virus vector.
    Wu Z; Wu X; Cao H; Dong X; Wang H; Hou Y
    Sci China C Life Sci; 2002 Feb; 45(1):96-104. PubMed ID: 18763068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scalable production of adeno-associated virus type 2 vectors via suspension transfection.
    Park JY; Lim BP; Lee K; Kim YG; Jo EC
    Biotechnol Bioeng; 2006 Jun; 94(3):416-30. PubMed ID: 16622883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Self-amplification system for recombinant adeno-associated virus production.
    Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
    Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Production of recombinant adeno-associated vectors using two bioreactor configurations at different scales.
    Negrete A; Kotin RM
    J Virol Methods; 2007 Nov; 145(2):155-61. PubMed ID: 17606302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery.
    Chahal PS; Schulze E; Tran R; Montes J; Kamen AA
    J Virol Methods; 2014 Feb; 196():163-73. PubMed ID: 24239634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous Collection of Adeno-Associated Virus from Producer Cell Medium Significantly Increases Total Viral Yield.
    Benskey MJ; Sandoval IM; Manfredsson FP
    Hum Gene Ther Methods; 2016 Feb; 27(1):32-45. PubMed ID: 26863210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production of recombinant adeno-associated virus vectors.
    Zolotukhin S
    Hum Gene Ther; 2005 May; 16(5):551-7. PubMed ID: 15916480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Scalable and Accurate Method for Quantifying Vector Genomes of Recombinant Adeno-Associated Viruses in Crude Lysate.
    Ai J; Ibraheim R; Tai PWL; Gao G
    Hum Gene Ther Methods; 2017 Jun; 28(3):139-147. PubMed ID: 28488944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimized production of high-titer recombinant adeno-associated virus in roller bottles.
    Liu YL; Wagner K; Robinson N; Sabatino D; Margaritis P; Xiao W; Herzog RW
    Biotechniques; 2003 Jan; 34(1):184-9. PubMed ID: 12545558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular design for recombinant adeno-associated virus (rAAV) vector production.
    Aponte-Ubillus JJ; Barajas D; Peltier J; Bardliving C; Shamlou P; Gold D
    Appl Microbiol Biotechnol; 2018 Feb; 102(3):1045-1054. PubMed ID: 29204900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy.
    Mietzsch M; Grasse S; Zurawski C; Weger S; Bennett A; Agbandje-McKenna M; Muzyczka N; Zolotukhin S; Heilbronn R
    Hum Gene Ther; 2014 Mar; 25(3):212-22. PubMed ID: 24299301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors influencing recombinant adeno-associated virus production.
    Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
    Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells.
    Smith RH; Levy JR; Kotin RM
    Mol Ther; 2009 Nov; 17(11):1888-96. PubMed ID: 19532142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.